-
Thematic Analysis
NewRNA-Based Drugs and the Impact of COVID-19
This report investigates the past, current and future landscape of RNA-Based drugs, and how the success of the COVID-19 vaccines may have impacted this. High level analysis of the key trends and movements within the pharmaceutical industry in reference to RNA technology is provided, allowing you to identify and discern the key points within this area.
-
Product Insights
Human SARS Coronavirus 2 RNA Dependent RNA Polymerase – Drugs In Development, 2023
Global Markets Direct’s Human SARS Coronavirus 2 RNA Dependent RNA Polymerase provides in depth analysis on Human SARS Coronavirus 2 RNA Dependent RNA Polymerase targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview...
-
Product Insights
16S Ribosomal RNA – Drugs In Development, 2023
Global Markets Direct’s 16S Ribosomal RNA provides in depth analysis on 16S Ribosomal RNA targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in 16S Ribosomal RNA targeted therapeutics...
-
Product Insights
DNA Directed RNA Polymerase – Drugs In Development, 2023
Global Markets Direct’s DNA Directed RNA Polymerase provides in depth analysis on DNA Directed RNA Polymerase targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in DNA Directed RNA...
-
Product Insights
Double Stranded RNA Specific Adenosine Deaminase – Drugs In Development, 2023
Global Markets Direct’s Double Stranded RNA Specific Adenosine Deaminase provides in depth analysis on Double Stranded RNA Specific Adenosine Deaminase targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved...
-
Product Insights
Probable ATP Dependent RNA Helicase DDX58 – Drugs In Development, 2023
Global Markets Direct’s Probable ATP Dependent RNA Helicase DDX58 provides in depth analysis on Probable ATP Dependent RNA Helicase DDX58 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved...
-
Product Insights
Interferon Induced Double Stranded RNA Activated Protein Kinase – Drugs In Development, 2023
Global Markets Direct’s Interferon Induced Double Stranded RNA Activated Protein Kinase provides in depth analysis on Interferon Induced Double Stranded RNA Activated Protein Kinase targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview...
-
Product Insights
NewLikelihood of Approval Analysis for Rhabdoviridae Infections
Overview How likely is it that the drugs in Rhabdoviridae Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rhabdoviridae Infections Overview The family Rhabdoviridae are negatively stranded RNA viruses consisting...
-
Product Insights
NewLikelihood of Approval Analysis for Picornaviridae Infections
Overview How likely is it that the drugs in Picornaviridae Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Picornaviridae Infections Overview The family PICORNAVIRIDAE comprises five genera, namely, enteroviruses, rhinoviruses,...
-
Product Insights
NewLikelihood of Approval Analysis for Hepacivirus Infections
Overview How likely is it that the drugs in Hepacivirus Infections will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hepacivirus Infections Overview Hepacivirus infections are caused by a genus of positive-strand...